The talk highlighted how economic evaluation can inform policy decisions and prioritise impactful AMR prevention strategies.
The session was co-hosted by #ESCMID, the Global Leaders Group on #AMR, #CARB-X, #LifeArc, #NovoNordiskFoundation, and #GatesFoundation.
#HealthEconomics #ESCMIDGlobal2026
Shiela from HITAP presented on “Cost-effectiveness of prevention strategies to mitigate antimicrobial resistance (AMR)” at the ESCMID Science-Policy Forum: Evidence for Policy – Modelling and Economics during ESCMID Global 2026 in Munich, Germany (17 April 2026).
3 models: info sharing | collective bargaining | central purchasing
⚙️ Success = political will + harmonisation + financing
🚀 Next steps: pilot small, commit politically, learn together
🌏 ASEAN is ready. Now it’s time to act.
What is this report about? 📑How can countries make antibiotics more affordable & accessible? Our study, HITAP, WHO & Global Antibiotic Research & Development Partnership (GARDP) reviewed 33 global mechanisms.
💡 What works
✅ better pricing
✅ reliable supply
✅ quality assurance
✅ regional solidarity
📢 New report released: Coordinated Procurement: Lessons Learned Globally, Potential ASEAN Applications, and Implications for Antibiotics Access and Policy
👉 Explore now: bit.ly/4tfvTWv
#SECURE #GARDP #AntibioticResistance #Antibiotics #AMR #HealthPolicy #UniversalHealthCoverage #PublicHealth
📃Shared experiences from Thailand & Southeast Asia on building HTA capacity to support better health decisions. 🎉
Across many countries, the question is no longer whether health policy should be evidence-informed—but how to make it happen in practice.🤝
📰Great to join the Health Economic Analysis for Evidence-Driven Health Policies workshop in Colombo (3–4 Mar).
#HTA #HealthEconomics #SriLanka
🎥 Watch the documentary on the clean water filtration innovation project in two pilot areas in Northern Thailand, featuring reflections from local communities on the outcomes observed: youtu.be/ofBXI5Odco0
#HITAP #MIDAS #NUS #CleanWater #HealthPolicy #Equity #GlobalHealth
💧 From clean water challenges in remote communities to innovation designed for real-world use and long-term sustainability.
🎥 Watch the video to explore how clean water connects evidence, policy, and impact: youtu.be/2lNsnnsVY7w
#HITAP #MIDAS #NUS #CleanWater #HealthPolicy #Equity #GlobalHealth
💧 Clean water is not only a basic need, but also a health policy priority.
🎥 This documentary highlights how addressing water access requires more than technology alone. It calls for evidence-informed policy, system-level thinking, and cross-sector collaboration.
🚨 Now on YouTube
How is Cochrane reshaping the evidence ecosystem?
Watch our HITAP Special Session with Ana Beatriz Pizarro and explore new ways to engage in global evidence synthesis.
🎥 youtu.be/LwtQiT6jx-k
#Cochrane #EvidenceSynthesis #GlobalHealth #HITAP
Great to see a growing community advancing evidence-informed health policy across the region. 👏
The workshop equipped researchers with practical skills to conduct model-based #economicevaluations using #Markovmodels in Excel, combining theory with hands-on model building and analysis. 📊
🎬 Watch the workshop highlights: youtu.be/06wOXvNlDiQ
Congratulations to all participants and partners who made this workshop a success! 🎉
#HealthEconomics #HealthTechnologyAssessment
#MarkovModel #EvidenceInformedPolicy #CapacityBuilding
🎉Celabrating the successful 4th Regional Workshop on Advanced #HealthEconomicEvaluation at JIPMER, Puducherry 🤝
🗝️ Participants gained hands-on skills in building #Markovmodels in Excel, conducting deterministic & probabilistic analyses, interpreting results, & reporting for peer-reviewed journals.
📍The reference case, methodology review, and systematic review/meta-analysis papers are all available at the link below:
🔗https://bit.ly/4s51t8I
🔗https://bit.ly/4rPSBEp
🔗https://bit.ly/3ZQvbSW
#HTA #EarlyHTA #PrecisionMedicine #HealthEconomics #LMICs #CostEffectiveness #EconomicEvaluation
How do we evaluate Precision Medicine from early R&D stage to market access, transparently and consistently❓
#PICCOTEAM offers
• 46 recommendations for conventional #EE
• 30 for early health technology assessment
💻 Tool to guide your analysis & generate structured reports:
piccoteam.gear4health.com
📃It was designed to expand choice but exposing ethical tensions and the delicate balance between access, quality, and integrity in UHC.
🔓 Full paper is ready now : rdcu.be/e4qK9
🚨 Access without safety isn’t progress—it’s systemic failure.
When access outpaces oversight, reforms can backfire. A new paper by Yot Teerawattananon (HITAP & SSHSPH of NUS) examines Thailand’s 2022 dialysis reform.
🔓 Read rdcu.be/e4qK9
🌍 Free for LICs via Research4Life: lnkd.in/g-GPuJN6
Key findings:
📊 C-section rates rose from 30% to 35% over five years
📊 Both clinical and non-clinical factors (age, region, hospital type, day of delivery) influenced use
📊 COVID-19 had no significant impact
#HITAP #HealthPolicy #UniversalCoverage #MaternalHealth #CaesareanSection #CSection
📢 New Publication Alert!
Are caesarean section rates in Thailand rising beyond what is medically necessary? 👶🏻
A new study by HITAP analyses national hospitalization data under Thailand’s Universal Coverage Scheme (2016–2021), covering over 500,000 C-section cases.
📃 bmjopen.bmj.com/content/16/2...
🔹Based on Thailand’s 2022 dialysis reform, the Commission examined system challenges, policy goals, and modeled policy options to assess impacts on dialysis systems in low- and middle-income countries.📃
🎥 Highlights now live: Nature Medicine Commission Report Launch on Dialysis Policy
▶️ youtu.be/ssncPDQDXtc
📄 Full report: www.nature.com/collections/...
#PMAC2026 #ChronicKidneyDisease #DialysisPolicy #ThailandUHC #LMICs
🗝️ The study shows significant gaps in animal and environmental data and calls for more representative evidence to guide policy.
📢 New Publication Alert:
🎉HITAP is excited to highlight a new open-access systematic review on data sources used in socioeconomic impact assessments of antimicrobial resistance from an One Health lens.
🔗Full article: bit.ly/4rUH7Pz
#OneHealth #AMR #HealthEconomics #HITAP
#PMAC2026 side meeting: #AMR in an ageing world— where rising infection risks demand policies that are both effective & equitable. We also proudly launched #GAPi in #Thailand to strengthen #antibioticpolicy through a health economics approach.
🎥Highlights: bit.ly/4bQZhwH
📃GAPi: bit.ly/3MkAwPc
⁉️What do you fund when resources are limited? Whose values count? What happens after a decision is made?
🗝️HTA is both a method and a process for priority setting
🗝️Policymakers seek evidence-informed, not purely evidence-based, decisions
🗝️Policy decisions are not linear and do not happen in isolation
What really happens when evidence meets policy?
🤝HITAP hosted the Duke–NUS #EMHEAL for a focused session on Health Technology Assessment. Together with healthcare leaders from across sectors, the conversation moved beyond frameworks to the realities of decision-making.
A new short course on “Vaccinology: Science and Public Health” is coming to Nagasaki, Japan. This course is designed for vaccine researchers and public health professionals involved in/or interested in vaccine research, development, epidemiology, policy, and implementation. Dates: 24–28 August 2026. Learn more & apply: https://www.tmgh.nagasaki-u.ac.jp/en/short-courses/vaccinology-science-and-public-health.
📢 Now Open for Applications!
A new short course on “Vaccinology: Science and Public Health” is coming to Nagasaki, Japan.
📅 Dates: 24–28 August 2026
🎓 Certificate of Participation awarded upon completion
🔗 Learn more & apply: www.tmgh.nagasaki-u.ac.jp/en/short-cou...